NCT01764178

To Evaluate the Safety and PK Characteristics in Healthy Volunteers-Livalozet

A Single Dose, Sequence-randomized, Open-label, 2x2 Crossover Study to Compare Pharmacokinetics Between Pitavastatn and Valsartan Co-administration and Livalo Complex Product in Healthy Male Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 52 (actual)
• Sponsor: JW Pharmaceutical · Industry
• Sex: Male
• Age: 20 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to compare pharmacokinetics between Pitavastatin and Valsartan co-administration and Livalo fixed combination drug in healthy male subjects.

Conditions

• Hyperlipidemia
• Hypertension

Interventions

Type	Name	Description
DRUG	Livalo fixed combination drug	Pitavastatin 4mg / Valsartan 160mg
DRUG	Pitavastatin, Valsartan	Pitavastatin 4mg, Valsartan 160mg

Timeline

• Start date: 2013-01-22
• Primary completion: 2013-03-15
• Completion: 2013-12-27
• First posted: 2013-01-09
• Last updated: 2025-09-09

Locations

1 site across 1 country: South Korea